Carlo Toniatti – CSO, IRBM
Carlo Toniatti, chief scientific officer of IRBM, gives his insights into how the increased participation of early-stage ventures in the drug R&D…
Lorna Warwick – CEO, Lymphoma Coalition
Lorna Warwick is CEO of the Lymphoma Coalition, a worldwide network of patient groups with a full or partial focus on providing support to patients…
Francis Van Parys – Vice President Commercial Asia-Pacific,…
Francis Van Parys, vice president commercial Asia-Pacific at Cytiva, a global life sciences leader dedicated to advancing and accelerating…
Nael Dabbagh – General Manager MENEAT, GE Healthcare
Over a decade ago, GE Healthcare selected Turkey as an international operational base for its Eastern and Africa Growth Markets (EAGM) and 84…
Dogan Taskent – Board Member, Swiss Chamber of Commerce,…
Dogan Taskent, board member of the Swiss Chamber of Commerce in Turkey, highlights Turkey’s successful response to the COVID-19 pandemic, how the…
Per E. Jørgensen – Deputy Director, Rigshospitalet,…
Per Jørgensen, deputy director of Copenhagen University Hospital (Rigshospitalet), discusses pandemic management, clinical trial collaborations with…
Petter Hartman – CEO, Medicon Valley Alliance
Petter Hartman of the Medicon Valley Alliance, a non-profit membership organisation spanning the Danish-Swedish life science cluster Medicon Valley,…
Natacha Bolaños – Global Alliances Manager & Regional…
The Lymphoma Coalition’s Natacha Bolaños outlines the fundamentals of the lymphoma patient experience today, the growing number of innovative new…
Karim Smaira – CEO & Kamel Ghammachi – Chairman,…
Kamel Ghammachi and Karim Smaira are the co-founders of Genpharm, an entrepreneurial success story that now provides market access and marketing…
Jean-Christophe Hyvert – President Biologics and Cell…
Swiss-based Lonza has consolidated as a titan in the CDMO industry with annual revenues of around CHF 5.9bn for 2020. Its president for the Biologics…
Güldem Berkman – General Manager Turkey, Amgen &…
Amgen, the American biotech giant, established a direct presence in Turkey in 2010 by acquiring a local generics manufacturer for US 700 million. Its…
Abidin Gülmüş – CEO, GEN
Few Turkish companies are experiencing such a transformational moment as GEN. Just in 2021, the Ankara-based organization made its public debut at the…